Trial intelligence / Profile preview

Phase III Study of M121101 Plus Overcurvature-Correcting Device in Pincer Nail

jRCT2031200264Phase 3Completed

Sponsor
Maruho Co., Ltd.
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in Pincer nail deformity comparing M121101 + device with Placebo + device (2 arms). Primary endpoint: Distal nail width narrowing rate. Started Oct 2020; status: completed.

02

Drugs

M121101
03

Conditions

Pincer nail deformity

Beyond the preview

Go deeper on jRCT2031200264.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2031200264.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call